Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SANUWAVE Health (SNWV) Enterprise Value (2016 - 2026)

SANUWAVE Health has reported Enterprise Value over the past 17 years, most recently at -$10.8 million for Q1 2026.

  • Quarterly Enterprise Value fell 26.8% to -$10.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$10.8 million through Mar 2026, down 26.8% year-over-year, with the annual reading at -$12.0 million for FY2025, 16.82% down from the prior year.
  • Enterprise Value was -$10.8 million for Q1 2026 at SANUWAVE Health, up from -$12.0 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$106000.0 in Q1 2023 and troughed at -$12.0 million in Q4 2025.
  • The 5-year median for Enterprise Value is -$2.5 million (2024), against an average of -$4.4 million.
  • Year-over-year, Enterprise Value skyrocketed 77.63% in 2023 and then tumbled 2669.81% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$1.2 million in 2022, then plummeted by 55.85% to -$1.8 million in 2023, then tumbled by 469.67% to -$10.2 million in 2024, then fell by 16.82% to -$12.0 million in 2025, then increased by 9.87% to -$10.8 million in 2026.
  • Per Business Quant, the three most recent readings for SNWV's Enterprise Value are -$10.8 million (Q1 2026), -$12.0 million (Q4 2025), and -$9.6 million (Q3 2025).